Showing papers by "Andrea Decensi published in 2002"

TL;DR: Fenretinide treatment was associated with a lower incidence of ovarian carcinoma during the intervention period but such a protective effect seems to disappear after treatment, and a possible protective effect of fen retinide in BRCA-mutated women was suggested.